Quick commerce in India has already transformed how people buy groceries and essentials. Its next frontier looks set to be healthcare. In that context, the new Zepto Orange Health diagnostics pilot is an early test of whether the same delivery rails can handle time sensitive medical services that demand accuracy and trust.
Zepto, known for its rapid delivery model, has launched a trial for in app diagnostic bookings through a partnership with diagnostics provider Orange Health. The offering, branded Zepto Diagnostics, is currently in beta across Bengaluru, Delhi NCR, Mumbai and Hyderabad.
How do Zepto and Orange Health work together in this pilot
Within the app, users can now book a range of tests, from full body check ups to routine blood work. Once a slot is confirmed, Orange Health handles both sample collection and report delivery, while Zepto provides the discovery and ordering layer.
The service promises sample collection within sixty minutes and reports in under six hours for participating cities. For urban users already comfortable with ordering groceries or food through quick commerce platforms, the experience is designed to feel familiar while addressing a very different need state.
Orange Health brings clinical credentials to the table. It holds National Accreditation Board for Testing and Calibration Laboratories accreditation in Bangalore, Noida, Hyderabad and Gurgaon, along with approvals from the Indian Council of Medical Research that align with national diagnostic standards. These accreditations indicate compliance with ISO 15189 2022, a global benchmark that requires not only technical competence but also robust management systems inside medical laboratories.
ADVERTISEMENT
What should users know about reliability and turnaround
While the promise is clear sample collection in an hour and reports within a few hours there is limited public data confirming on time performance across all launch cities. The absence of verified metrics makes it difficult to judge how consistently the model can meet its targets, especially if demand spikes or logistics face pressure.
This uncertainty matters because diagnostics requires precision and predictability. Late or mishandled reports can affect treatment decisions, and users may be less forgiving of delays than they might be with a grocery order. As Zepto Diagnostics scales, the ability to maintain advertised turnaround times will be a key test of the model resilience.
How does this move fit into the wider quick commerce healthcare push
The Zepto Orange Health diagnostics pilot does not exist in isolation. Other platforms in India have already explored healthcare adjacencies, particularly in medicine delivery. Blinkit, BigBasket, Swiggy Instamart and Flipkart Minutes have all moved into quick medicine supply, hinting at a broader appetite for time bound health related services on rapid delivery networks.
For business to business vendors, this opens new routes into healthcare enabled quick commerce, including
-
Phlebotomy staffing for reliable doorstep sample collection
ADVERTISEMENT
-
Cold chain logistics to keep samples within required temperature ranges
-
Consent management systems that capture and store patient approvals securely
Companies with payment infrastructure, such as gateways and subscription billing platforms, can also see opportunity in recurring revenue flows tied to chronic care diagnostics and medication. Compared with everyday groceries, healthcare typically offers higher customer lifetime value, which can justify deeper investment in compliance and service quality.
Is quick commerce ready to handle healthcare expectations
The move into diagnostics raises important questions. Can dark store style networks and micro fulfilment centres, like those used by Blinkit, Instamart and Zepto, adapt to the stricter demands of medical logistics The numbers underline the scale of infrastructure already in place. Blinkit runs hundreds of dark stores, Instamart operates a sizeable network and Zepto has built its own footprint of local hubs.
However, healthcare expectations are different from snack delivery. Data security, consent, sample integrity and regulatory compliance all sit at the forefront. Platforms will need to prove that their systems can meet these requirements consistently, not just in pilot phases.
For now, the Zepto Diagnostics beta provides a controlled space to test demand, identify operational bottlenecks and refine coordination between the app layer and Orange Health laboratory operations.
ADVERTISEMENT
By embedding lab test bookings inside a familiar quick commerce interface, the Zepto Orange Health diagnostics pilot offers a glimpse of how rapid delivery platforms might move deeper into healthcare, but its long term success will depend on whether promised speed, quality and regulatory discipline can match the higher stakes of medical diagnostics at scale.
Follow Marketing Moves on Instagram and Facebook for industry insights, strategy breakdowns, and brand transformation stories.
